CEO Dr. Jennifer Bath of Immunoprecise Antibodies Ltd. (OTCQB: IPATF)

Apr 25, 2019, 12:30 PM

CEO Dr. Jennifer Bath of Immunoprecise Antibodies Ltd. (OTCQB: IPATF), joins the show to discuss antibody discovery platforms, recent revenue growth, and providing solutions for the global research industry.

B cell Select™ # Canada # DeepDisplay™ # Health # Hybridoma Licensing # OmniAb® animals # pharmaceutical # products # proprietary technologies # Victoria